Peter Chiarelli, MD, DPhil News

Poster session finalists were voted on by a scientific committee and presented key takeaways from their research during Science Day 2024.

A Children’s Hospital Los Angeles team developed the test, which is the first to precisely measure how much cerebrospinal fluid is flowing through a shunt.

Investigators are exploring a novel use for nanoparticles: enhancing radiation therapy for an aggressive childhood brain tumor.

Two federal grants are supporting efforts at Children’s Hospital Los Angeles to develop novel therapies for this aggressive childhood brain tumor.

Dr. Chiarelli's passion for research began as an undergraduate at Pomona College, when he worked at Los Alamos National Laboratory by invitation from a faculty mentor.

Inspired by fictional and real-life heroes, Daniel is bravely tackling medulloblastoma alongside a team of experts in the Cancer and Blood Disease Institute at Children’s Hospital Los Angeles.

Born at 25 weeks and just 2 pounds, Lincoln faces the precarious life of a micropreemie. But he has help—the vigilance of his parents and the expertise of multiple CHLA specialists.

Peter Chiarelli, MD, DPhil, is combining chemistry, physics and nanoscience to find new therapies for diffuse intrinsic pontine gliomas.

When it comes to pediatric brain cancers, research and treatments have made great strides. But some cancers do not respond to conventional treatments or grow deep within delicate areas of the brain